Thus, components of the IFN-γ signaling axis were confirmed as mechanistic targets of linoleate and butanoate metabolites in cell–based assays, and in the colon tumors from rats fed SPI on a chronic basis, but not SPI3d. The gene discussed is IFNG; the disease is colonic neoplasm.